Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 2
2017 3
2018 11
2019 14
2020 15
2021 23
2022 21
2023 13
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
Choueiri TK, Powles T, Albiges L, Burotto M, Szczylik C, Zurawski B, Yanez Ruiz E, Maruzzo M, Suarez Zaizar A, Fein LE, Schutz FA, Heng DYC, Wang F, Mataveli F, Chang YL, van Kooten Losio M, Suarez C, Motzer RJ; COSMIC-313 Investigators. Choueiri TK, et al. N Engl J Med. 2023 May 11;388(19):1767-1778. doi: 10.1056/NEJMoa2212851. N Engl J Med. 2023. PMID: 37163623 Free PMC article. Clinical Trial.
Publisher Erratum zu: Digitalisierung in der Urologie – Herausforderung und Chance.
AK Informationstechnologie und Dokumentation (IT@DOC) (DGU), AK Versorgungsforschung, Qualität und Ökonomie (DGU); AK Informationstechnologie und Dokumentation (IT@DOC) (DGU); AK Versorgungsforschung, Qualität und Ökonomie (DGU); AK Bildgebende Systeme (DGU), Sektion Urologie (DEGUM); Witzsch UKF, Borkowetz A, Enzmann T, Rodler S, Leyh-Bannurah SR, Loch T, Borgmann H, Steidle O. AK Informationstechnologie und Dokumentation (IT@DOC) (DGU), AK Versorgungsforschung, Qualität und Ökonomie (DGU), et al. Among authors: borkowetz a. Urologie. 2023 Oct;62(10):1094. doi: 10.1007/s00120-023-02196-0. Urologie. 2023. PMID: 37642684 German. No abstract available.
[Digitalization in urology-challenge and opportunity].
AK Informationstechnologie und Dokumentation (IT@DOC) (DGU), AK Versorgungsforschung, Qualität und Ökonomie (DGU); AK Informationstechnologie und Dokumentation (IT@DOC) (DGU); AK Versorgungsforschung, Qualität und Ökonomie (DGU); AK Bildgebende Systeme (DGU), Sektion Urologie (DEGUM); Witzsch UKF, Borkowetz A, Enzmann T, Rodler S, Leyh-Bannurah SR, Loch T, Borgmann H, Steidle O. AK Informationstechnologie und Dokumentation (IT@DOC) (DGU), AK Versorgungsforschung, Qualität und Ökonomie (DGU), et al. Among authors: borkowetz a. Urologie. 2023 Sep;62(9):913-928. doi: 10.1007/s00120-023-02154-w. Epub 2023 Aug 22. Urologie. 2023. PMID: 37606658 Review. German.
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium.
Omar MI, MacLennan S, Ribal MJ, Roobol MJ, Dimitropoulos K, van den Broeck T, MacLennan SJ, Axelsson SE, Gandaglia G, Willemse PP, Mastris K, Ransohoff JB, Devecseri Z, Abbott T, De Meulder B, Bjartell A, Asiimwe A, N'Dow J; PIONEER Consortium. Omar MI, et al. Nat Rev Urol. 2023 Aug;20(8):494-501. doi: 10.1038/s41585-023-00748-9. Epub 2023 Apr 3. Nat Rev Urol. 2023. PMID: 37012441 Review.
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
Gorodetska I, Offermann A, Püschel J, Lukiyanchuk V, Gaete D, Kurzyukova A, Freytag V, Haider MT, Fjeldbo CS, Di Gaetano S, Schwarz FM, Patil S, Borkowetz A, Erb HHH, Baniahmad A, Mircetic J, Lyng H, Löck S, Linge A, Lange T, Knopf F, Wielockx B, Krause M, Perner S, Dubrovska A. Gorodetska I, et al. Among authors: borkowetz a. Theranostics. 2024 Jan 1;14(2):714-737. doi: 10.7150/thno.88057. eCollection 2024. Theranostics. 2024. PMID: 38169509 Free PMC article.
[Metastasis-directed therapy in prostate cancer].
Borkowetz A, Hölscher T. Borkowetz A, et al. Urologie. 2024 Mar;63(3):225-233. doi: 10.1007/s00120-024-02281-y. Epub 2024 Feb 22. Urologie. 2024. PMID: 38388789 Review. German.
Gender-specific outcomes in immune checkpoint inhibitor therapy for advanced or metastatic urothelial cancer: a systematic review and meta-analysis.
Schneidewind L, Kiss B, Zengerling F, Borkowetz A, Graf S, Kranz J, Dräger DL, Graser A, Bellut L, Uhlig A. Schneidewind L, et al. Among authors: borkowetz a. J Cancer Res Clin Oncol. 2023 Sep;149(11):9399-9408. doi: 10.1007/s00432-023-04788-x. Epub 2023 Apr 20. J Cancer Res Clin Oncol. 2023. PMID: 37079051 Free PMC article. Review.
Decreasing Non-bladder-cancer Mortality After Radical Cystectomy.
Froehner M, Koch R, Heberling U, Borkowetz A, Hübler M, Novotny V, Wirth MP, Thomas C. Froehner M, et al. Among authors: borkowetz a. Eur Urol Open Sci. 2021 May 18;29:15-18. doi: 10.1016/j.euros.2021.04.007. eCollection 2021 Jul. Eur Urol Open Sci. 2021. PMID: 34337529 Free PMC article.
German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy.
Borkowetz A, Blana A, Böhmer D, Cash H, Ehrmann U, Franiel T, Henkel TO, Höcht S, Kristiansen G, Machtens S, Niehoff P, Penzkofer T, Pinkawa M, Radtke JP, Roth W, Witzsch U, Ganzer R, Schlemmer HP, Grimm MO, Hakenberg OW, Schostak M. Borkowetz A, et al. Urol Int. 2022;106(5):431-439. doi: 10.1159/000521882. Epub 2022 Feb 10. Urol Int. 2022. PMID: 35144260 Free PMC article. Review.
Reply by Authors.
Baunacke M, Schmidt ML, Groeben C, Borkowetz A, Thomas C, Koch R, Chun FKH, Ihrig A, Weissbach L, Huber J. Baunacke M, et al. Among authors: borkowetz a. J Urol. 2020 Mar;203(3):560-561. doi: 10.1097/JU.0000000000000541.03. Epub 2019 Dec 3. J Urol. 2020. PMID: 31794360 No abstract available.
91 results